SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001453356-11-000008
Filing Date
2011-07-27
Accepted
2011-07-27 12:55:23
Documents
1
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4/A  
1 PRIMARY DOCUMENT primary_doc.xml 4/A 17989
  Complete submission text file 0001453356-11-000008.txt   20251
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1099 FOREST LAKE TERRACE NICEVILLE FL 32578
Business Address 1099 FOREST LAKE TERRACE NICEVILLE FL 32578 208-263-6695
10X Fund, L.P. (Reporting) CIK: 0001453356 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 001-31791 | Film No.: 11989496

Mailing Address 1099 FOREST LAKE TERRACE NICEVILLE FL 32578
Business Address 1099 FOREST LAKE TERRACE NICEVILLE FL 32578 850-502-7659
10X Capital Management, LLC (Reporting) CIK: 0001457247 (see all company filings)

State of Incorp.: FL | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 001-31791 | Film No.: 11989495